Peptide stabilized amphotericin B nanodisks

Peptides

Volumn 28, Issue 4, 2007, Pages 741-746

  Tufteland, Megan ^a   Pesavento, Joseph B ^b   Bermingham, Rachelle L ^b   Hoeprich Jr , Paul D ^b   Ryan, Robert O ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b Materials   (United States)

Author keywords

Amphotericin B; Apolipoprotein A I; Dimyristoylphosphatidylcholine; Electron microscopy; Nanodisk; Peptide

Indexed keywords

ACYLASPARTYLTRYPTOPHYLPHENYLALANYLLYSYLALANYLPHENYL ALANYLTYROSYLASPARTYLLYSYLVALYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYL GLUTAMYLALANYLPHENYLALANYLAMIDE; AMPHOTERICIN B; APOLIPOPROTEIN A; PEPTIDE DERIVATIVE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; DRUG STABILITY; ELECTRON MICROSCOPY; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; APOLIPOPROTEIN A-I; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; NANOPARTICLES; NANOTECHNOLOGY; PEPTIDES; PHOSPHOLIPIDS; SPECTROMETRY, FLUORESCENCE;

FUNGI;

EID: 33847368138     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.01.007     Document Type: Article

References (16)

1. Bolard J., Legrand P., Heitz F., and Cybulska B. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30 (1991) 5707-5715
2. Datta G., Chaddha M., Hama S., Navab M., Fogelman A.M., Garber D.W., et al. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res 42 (2001) 1096-1104
3. Davidson W.S., and Silva R.A. Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. Curr Opin Lipidol 16 (2005) 295-300
4. Hristova K., Wimley W.C., Mishra V.K., Anantharamiah G.M., Segrest J.P., and White S.H. An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method. J Mol Biol 290 (1999) 99-117
5. Mishra V.K., Anantharamaiah G.M., Segrest J.P., Palgunachari M.N., Chaddha M., Sham S.W., et al. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide lipid discoidal complexes. J Biol Chem 281 (2006) 6511-6519
6. Navab M., Anantharamaiah G.M., Reddy S.T., Hama S., Hough G., Grijalva V.R., et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol 25 (2005) 1325-1331
7. Navab M., Anantharamaiah G., Reddy S.T., Van Lenten B.J., Datta G., Garber D., et al. Potential clinical utility of high-density lipoprotein-mimetic peptides. Curr Opin Lipidol 17 (2006) 440-444
8. Nelson K.G., Bishop J., Ryan R.O., and Titus R. Nanodisk-associated amphotericin B fully clears Leishmania major infection in susceptible BALB/c mice. Antimicrob Agents Chemother 50 (2005) 1238-1244
9. Oda M.N., Hargreaves P., Beckstead J.A., Redmond K.A., Van Antwerpen R., and Ryan R.O. Reconstituted high-density lipoprotein enriched with the polyene antibiotic, amphotericin B. J Lipid Res 47 (2005) 260-267
10. Pfaller M.A., and Barry A.L. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 32 (1994) 1992-1996
11. Pownall H.J., Massey J.B., Kusserow S.K., and Gotto A.M. Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry 17 (1978) 1183-1188
12. Ryan R.O., Forte T.M., and Oda M.N. Optimized bacterial expression of human apolipoprotein A-I. Protein Exp Purif 27 (2003) 98-103
13. Segrest J.P., Garber D.W., Brouillette C.G., Harvey S.C., and Anantharamaiah G.M. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem 45 (1994) 303-369
14. Tall A.R., Small D.M., Deckelbaum R.J., and Shipley G.G. Structure and thermodynamic properties of high density lipoprotein recombinants. J Biol Chem 252 (1977) 4701-4711
15. Tiballi R.N., He X., Zarins L.T., Revankar S.G., and Kauffman C.A. Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol 33 (1995) 915-917
16. Weers P.M.M., Narayanaswami V., and Ryan R.O. Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3. Eur J Biochem 268 (2001) 3728-3735